| Study |
Reference |
|
Abd Rahman, 2020
|
Abd Rahman New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre. Rev Bras Ginecol Obstet 2020; 42:705-711
|
|
Al Arfaj, 2010
|
Al Arfaj Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus 2010; 19:1665-73
|
|
Andersson (Controls exposed to corticosteroides), 2021
|
Andersson Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study. Rheumatology (Oxford) 2021; 60:2317-2326
|
|
Andersson (Controls unexposed, NOS), 2021
|
Andersson Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study. Rheumatology (Oxford) 2021; 60:2317-2326
|
|
Andreoli, 2022
|
Andreoli Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals. Clin Rev Allergy Immunol 2022; 62:346-353
|
|
Baalbaki, 2020
|
Baalbaki Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine. Ochsner J 2020; 20:362-367 Baalbaki, S. Systemic lupus erythematosus: Outcomes in women treated with and without hydroxychloroquine Am. J. Obstet. Gynecol. 2015; 212:S273-.
|
|
Bérard, 2021
|
Bérard Available medications used as potential therapeutics for COVID-19: What are the known safety profiles in pregnancy. PLoS One 2021; 16:e0251746
|
|
Braga, 2021
|
Braga Systemic lupus erythematosus and pregnancy: A retrospective single-center study of 215 pregnancies from Portugal. Lupus 2021; 30:2165-2175
|
|
Buchanan, 1996
|
Buchanan Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. Ann. Rheum. Dis. 1996; 55:486-8 Khamashta The use of hydroxychloroquine in lupus pregnancy: the British experience. Lupus 1996; 5 Suppl 1:S65-6
|
|
Canti, 2021
|
Canti Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine. Immunol Med 2021; 44:204-210
|
|
Chakravarty, 2005
|
Chakravarty Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am. J. Obstet. Gynecol. 2005; 192:1897-904
|
|
Chambers (Controls unexposed, disease free), 2022
|
Chambers Birth Outcomes in Women Who Have Taken Hydroxycholoroquine During Pregnancy: A Prospective Cohort Study. Arthritis Rheumatol 2022; 74:711-724
|
|
Chambers (Controls unexposed, sick), 2022
|
Chambers Birth Outcomes in Women Who Have Taken Hydroxycholoroquine During Pregnancy: A Prospective Cohort Study. Arthritis Rheumatol 2022; 74:711-724
|
|
Cimaz, 2007
|
Cimaz Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disorders. Lupus 2007; 16:129-32
|
|
Clowse, 2006
|
Clowse Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006; 54:3640-7
|
|
Colvin, 2010
|
Colvin Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens. Pharmacoepidemiol Drug Saf 2010; 19:1137-50
|
|
Cooper (controls exposed to TNF-I), 2014
|
Cooper Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy. 2014; 66:444-50
|
|
Cooper (controls unexposed, sick), 2014
|
Cooper Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy. 2014; 66:444-50
|
|
Costedoat-Chalumeau, 2003
|
Costedoat-Chalumeau Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum. 2003; 48:3207-11
|
|
Diav-Citrin, 2013
|
Diav-Citrin Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study. Reprod. Toxicol. 2013; 39:58-62
|
|
Do, 2020
|
Do Does Hydroxychloroquine Protect against Preeclampsia and Preterm Delivery in Systemic Lupus Erythematosus Pregnancies? Am J Perinatol 2020; :
|
|
Frassi, 2004
|
Frassi Hydroxychloroquine in pregnant patients with rheumatic disease: a case control observation of 76 treated pregnancies. Lupus. 2004;13:755.
|
|
Gernaat (Controls unexposed, disease free), 2022
|
Gernaat Gestational Diabetes Mellitus Risk in Pregnant Women With Systemic Lupus Erythematosus. J Rheumatol 2022; 49:465-469
|
|
Gernaat (Controls unexposed, sick), 2022
|
Gernaat Gestational Diabetes Mellitus Risk in Pregnant Women With Systemic Lupus Erythematosus. J Rheumatol 2022; 49:465-469
|
|
Haase, 2020
|
Haase, I. Safety and beneficial effects of hydroxychloroquine on pregnancy outcomes in women with systemic lupus erythematosus Ann. Rheum. Dis. 2020; 79:1486-.
|
|
Haase, 2021
|
Haase, I. Sle pregnancies at high risk for preeclampsia benefit most from combination of low dose aspirin and hydroxychloroquine Ann. Rheum. Dis. 2021; 80:1195-.
|
|
He, 2022
|
He Pregnancy outcomes in Takayasu arteritis patients. Semin Arthritis Rheum 2022; 55:152016
|
|
Howley - BDS study, 2021
|
Howley Maternal exposure to hydroxychloroquine and birth defects. Birth Defects Res 2021; 113:1245-1256
|
|
Howley - NBDPS study, 2021
|
Howley Maternal exposure to hydroxychloroquine and birth defects. Birth Defects Res 2021; 113:1245-1256
|
|
Howren, 2020
|
Howren Perinatal exposure to conventional synthetic disease-modifying anti-rheumatic drugs in women with rheumatic disease and neonatal outcomes: a population-based study. Clin. Exp. Rheumatol. 2020; :
|
|
Huybrechts (Controls unexposed, NOS), 2021
|
Huybrechts Hydroxychloroquine early in pregnancy and risk of birth defects. Am J Obstet Gynecol 2021; 224:290.e1-290.e22
|
|
Huybrechts (Controls unexposed, sick), 2021
|
Huybrechts Hydroxychloroquine early in pregnancy and risk of birth defects. Am J Obstet Gynecol 2021; 224:290.e1-290.e22
|
|
Kiatkongchuchai, 2020
|
Kiatkongchuchai, P. Factors associated with preeclampsia in SLE patients during pregnancy Int. J. Rheum. Dis. 2020; 23:300-.
|
|
Kroese, 2017
|
Kroese Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births. J Immunol Res 2017; 2017:2810202
|
|
Langen, 2014
|
Langen High rate of preterm birth in pregnancies complicated by rheumatoid arthritis. Am J Perinatol 2014; 31:9-14
|
|
Leroux, 2015
|
Leroux Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study. Lupus 2015; 24:1384-91
|
|
Levy, 2001
|
Levy Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 2001; 10:401-4
|
|
Liu, 2021
|
Liu Effect of hydroxychloroquine on preeclampsia in lupus pregnancies: a propensity score-matched analysis and meta-analysis. Arch Gynecol Obstet 2021; 303:435-441
|
|
Louthrenoo, 2021
|
Louthrenoo Predicting factors of adverse pregnancy outcomes in Thai patients with systemic lupus erythematosus: A STROBE-compliant study. Medicine (Baltimore) 2021; 100:e24553
|
|
Mollerach, 2019
|
Mollerach Causes of fetal third-degree atrioventricular block and use of hydroxychloroquine in pregnant women with Ro/La antibodies. Clin. Rheumatol. 2019; 38:2211-2217
|
|
Moroni, 2016
|
Moroni Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. J. Autoimmun. 2016; 74:6-12
|
|
Placais, 2019
|
Placais Obstetrical morbidity related to anti-SSA antibodies: Data from a French monocentric retrospective study. Joint Bone Spine 2019; 86:523-524
|
|
Poh, 2020
|
Poh Maternal and Fetal Outcomes in Systemic Lupus Erythematosus Pregnancies. Ann Acad Med Singap 2020; 49:963-970
|
|
Reynolds, 2022
|
Reynolds Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine. Rheumatology (Oxford) 2022; :
|
|
Seo, 2019
|
Seo Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia. Lupus 2019; 28:722-730
|
|
Tang, 2022
|
Tang The efficacy and safety of hydroxychloroquine in pregnant patients with IgA nephropathy: A retrospective cohort study. Nephrology (Carlton) 2022; 27:155-161
|
|
Tincani, 2005
|
Tincani Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. Autoimmun Rev 2005; 4:423-8
|
|
Viktil (Controls exposed to other treatments), 2012
|
Viktil Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J Rheumatol 2012; 41:196-201
|
|
Viktil (Controls unexposed, NOS), 2012
|
Viktil Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J Rheumatol 2012; 41:196-201
|
|
Vroom (controls exposed to sulfasalazine), 2009
|
Vroom Drug use in pregnancy: exploring the field of Disease Modifying Antirheumatic Drugs in pregnancy Thesis, DMARDs in pregnancy: birth outcomes after prescribing DMARDs using the GPRD, 2009, 207p.
|
|
Vroom (controls unexposed, disease free), 2009
|
Vroom Drug use in pregnancy: exploring the field of Disease Modifying Antirheumatic Drugs in pregnancy Thesis, DMARDs in pregnancy: birth outcomes after prescribing DMARDs using the GPRD, 2009, 207p.
|
|
Zhang, 2022
|
Zhang Clinical study of factors associated with pregnancy outcomes in pregnant women with systemic lupus erythematosus in the southern China. Arch Rheumatol 2022; 37:59-66
|
